Patents by Inventor Heejeong Yoon

Heejeong Yoon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antisense oligonucleotides that inhibit expression of HIF-1
    Patent number: 7205283
    Abstract: New antisense oligonucleotide compounds, RX-0047 and RX-0149, inhibit expression of HIF-1 and also induce cytotoxicity in several cancer cell lines.
    Type: Grant
    Filed: January 28, 2004
    Date of Patent: April 17, 2007
    Assignee: Rexahn Corporation
    Inventors: Heejeong Yoon, Lingjun Mao, Young Bok Lee, Chang-Ho Ahn, Xiaoming Jiang
  • Use of antisense oligonucleotides to inhibit the expression of human Akt-1
    Patent number: 7122527
    Abstract: New antisense oligonucleotide compounds inhibit expression of Akt-1 and also induce cytotoxicity in several cancer cell lines.
    Type: Grant
    Filed: August 13, 2003
    Date of Patent: October 17, 2006
    Assignee: Rexahn Corporation
    Inventors: Heejeong Yoon, Lingjun Mao, Young Bok Lee, Chang Ho Ahn
  • Use of antisense oligonucleotides to inhibit the expression of human Akt-1
    Publication number: 20040265999
    Abstract: New antisense oligonucleotide compounds inhibit expression of Akt-1 and also induce cytotoxicity in several cancer cell lines.
    Type: Application
    Filed: August 13, 2003
    Publication date: December 30, 2004
    Inventors: Heejeong Yoon, Lingjun Mao, Young Bok Lee, Chang Ho Ahn
  • Antisense oligonucleotides that inhibit expression of HIF-1
    Publication number: 20040152655
    Abstract: New antisense oligonucleotide compounds, RX-0047 and RX-0149, inhibit expression of HIF-1 and also induce cytotoxicity in several cancer cell lines.
    Type: Application
    Filed: January 28, 2004
    Publication date: August 5, 2004
    Inventors: Heejeong Yoon, Lingjun Mao, Young Bok Lee, Chang-Ho Ahn, Xiaoming Jiang